AACC Middle East
AACC Middle East is a two-day scientific meeting and clinical laboratory exposition which will bring AACC scientific leadership to a region where there are great interest and enthusiasm for the latest education in laboratory science and diagnostic technology.
Learn about the latest scientific advances in laboratory medicine:
› Laboratory Quality Management and Accreditation
› Clinical Chemistry
› Newborn Screening
› Emerging Topics to the Middle East
AACC Middle East
Leaders in laboratory science and management from countries throughout the region including Bahrain, Kuwait, Qatar, Saudi Arabia, United Arab Emirates, Oman, Jordan, Egypt, Turkey, Lebanon, Cyprus, and the entire African continent will be invited to participate. Attendees are comprised of laboratory directors and managers, government officials, and representatives of the diagnostics industry.
Delivering the latest scientific advances in all disciplines pertinent to the field of laboratory medicine. Leaders in laboratory science and management from countries throughout the region including Bahrain, Kuwait, Qatar, Saudi Arabia, United Arab Emirates, Oman, Jordan, Egypt, Turkey, Lebanon, Cyprus, and the entire African continent will be invited to participate. Attendees will include laboratory directors and managers, government officials, and representatives of the diagnostics industry.
AACC Middle East will feature AACC’s globally-renowned education and scientific programs paired with a dynamic exposition and will showcase the latest developments in clinical laboratory medicine, innovations from the in vitro diagnostics industry, and best practices from experts in the field.
This 2-day conference will include emerging topics relevant to the Middle East, while the exposition will highlight the latest advances in mobile health, molecular diagnostics, mass spectrometry, next-generation sequencing, point-of-care, and automation.
DELIVERING THE LATEST SCIENTIFIC ADVANCES IN ALL DISCIPLINES PERTINENT TO THE FIELD OF LABORATORY MEDICINE.
Quality and Lab Management
› Jumping the Pediatric Reference Interval Hurdles
› Biological Variation: Improved Interpretation of Lab Results and Reduced False Rejections for QC
› Overdiagnosis and Over monitoring – Can We Do Better?
› Rule-Based Strategies for Improving Laboratory Utilization Management
› Minimum Retesting Intervals (MRI): Importance, Determination, Advantages, Challenges of Enforcement
Autoimmunity and Transplantation Medicine
› Developing Standards in Antinuclear Antibody Indirect Immunofluorescence (ANA IFA) Interpretation and Reporting
› Emerging Trends in Autoimmune and Paraneoplastic Encephalopathy Testing
› The Role of Clinical Laboratory in Transplantation
Clinical Chemistry's Hot Topics
› The Quantified Self and Wellness Monitoring: Actionable Data or Harmful Information?
› Cervical Cancer Screening as an Example of a Global Health Strategy in Resource‐limited Countries
› What Does the Physician Need from the Laboratory?
› A Dirty Assay: Challenges of PTH Estimation and Progress in PTH Harmonization
› Update on Gestational Diabetes Mellitus: Current National and International Diagnostic Criteria
› Real Global News: It’s Time to Embrace High Sensitivity Cardiac Troponin Assays With Cost Benefit Strategies For Early Rule-Out and Rule-In of My
› Clinical Cardiovascular Genomics Bootcamp
› Lipoprotein-related Precision Medicine – Implications in Risk Stratification and Emerging Therapies of Coronary Heart Disease and Aortic Valve D
› Standardization of Traditional and New Cardiovascular Disease Biomarkers – Addressing Cholesterol and Beyond
› Pharmacogenomics in Laboratory Medicine: Moving to an Era of Precision Medicine
› Emerging Clinical Applications of Circulating DNA Analysis
› Quality Control and Quality Assurance in the Era of Next Generation Sequencing
› Noninvasive Prenatal Testing by Cell-Free Fetal DNA: Translating Innovation into Clinical Practice